UniProt ID | RL15_HUMAN | |
---|---|---|
UniProt AC | P61313 | |
Protein Name | 60S ribosomal protein L15 | |
Gene Name | RPL15 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 204 | |
Subcellular Localization |
Membrane Lipid-anchor . |
|
Protein Description | ||
Protein Sequence | MGAYKYIQELWRKKQSDVMRFLLRVRCWQYRQLSALHRAPRPTRPDKARRLGYKAKQGYVIYRIRVRRGGRKRPVPKGATYGKPVHHGVNQLKFARSLQSVAEERAGRHCGALRVLNSYWVGEDSTYKFFEVILIDPFHKAIRRNPDTQWITKPVHKHREMRGLTSAGRKSRGLGKGHKFHHTIGGSRRAAWRRRNTLQLHRYR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Myristoylation | ------MGAYKYIQE ------CCHHHHHHH | 37.30 | 25255805 | |
5 | Ubiquitination | ---MGAYKYIQELWR ---CCHHHHHHHHHH | 35.03 | - | |
5 | Acetylation | ---MGAYKYIQELWR ---CCHHHHHHHHHH | 35.03 | 25825284 | |
6 | Phosphorylation | --MGAYKYIQELWRK --CCHHHHHHHHHHH | 8.65 | 28152594 | |
14 | 2-Hydroxyisobutyrylation | IQELWRKKQSDVMRF HHHHHHHCHHHHHHH | 46.60 | - | |
34 | Phosphorylation | CWQYRQLSALHRAPR HHHHHHHHHHHCCCC | 22.05 | 23401153 | |
47 | Ubiquitination | PRPTRPDKARRLGYK CCCCCCCHHHHHCCE | 46.61 | - | |
47 | 2-Hydroxyisobutyrylation | PRPTRPDKARRLGYK CCCCCCCHHHHHCCE | 46.61 | - | |
54 | Ubiquitination | KARRLGYKAKQGYVI HHHHHCCEECCCEEE | 47.51 | - | |
54 | Methylation | KARRLGYKAKQGYVI HHHHHCCEECCCEEE | 47.51 | 23748837 | |
56 | 2-Hydroxyisobutyrylation | RRLGYKAKQGYVIYR HHHCCEECCCEEEEE | 39.85 | - | |
56 | Ubiquitination | RRLGYKAKQGYVIYR HHHCCEECCCEEEEE | 39.85 | 21890473 | |
56 | Ubiquitination | RRLGYKAKQGYVIYR HHHCCEECCCEEEEE | 39.85 | 21890473 | |
56 | Ubiquitination | RRLGYKAKQGYVIYR HHHCCEECCCEEEEE | 39.85 | 21890473 | |
59 | Phosphorylation | GYKAKQGYVIYRIRV CCEECCCEEEEEEEE | 4.91 | 20007894 | |
62 | Phosphorylation | AKQGYVIYRIRVRRG ECCCEEEEEEEECCC | 7.02 | 28152594 | |
77 | Ubiquitination | GRKRPVPKGATYGKP CCCCCCCCCCCCCCC | 62.50 | - | |
80 | Phosphorylation | RPVPKGATYGKPVHH CCCCCCCCCCCCCCC | 41.28 | 28152594 | |
81 | Phosphorylation | PVPKGATYGKPVHHG CCCCCCCCCCCCCCH | 23.71 | 28152594 | |
83 | Ubiquitination | PKGATYGKPVHHGVN CCCCCCCCCCCCHHH | 33.19 | 21890473 | |
83 | Sumoylation | PKGATYGKPVHHGVN CCCCCCCCCCCCHHH | 33.19 | 28112733 | |
83 | Ubiquitination | PKGATYGKPVHHGVN CCCCCCCCCCCCHHH | 33.19 | 21890473 | |
83 | Ubiquitination | PKGATYGKPVHHGVN CCCCCCCCCCCCHHH | 33.19 | 21890473 | |
83 | Acetylation | PKGATYGKPVHHGVN CCCCCCCCCCCCHHH | 33.19 | 23749302 | |
93 | Ubiquitination | HHGVNQLKFARSLQS CCHHHHHHHHHHHHH | 27.49 | 21890473 | |
93 | Ubiquitination | HHGVNQLKFARSLQS CCHHHHHHHHHHHHH | 27.49 | 21890473 | |
93 | Ubiquitination | HHGVNQLKFARSLQS CCHHHHHHHHHHHHH | 27.49 | 21890473 | |
93 | 2-Hydroxyisobutyrylation | HHGVNQLKFARSLQS CCHHHHHHHHHHHHH | 27.49 | - | |
93 | Acetylation | HHGVNQLKFARSLQS CCHHHHHHHHHHHHH | 27.49 | 25825284 | |
97 | Phosphorylation | NQLKFARSLQSVAEE HHHHHHHHHHHHHHH | 27.60 | 29255136 | |
100 | Phosphorylation | KFARSLQSVAEERAG HHHHHHHHHHHHHHH | 28.70 | 23911959 | |
105 | Methylation | LQSVAEERAGRHCGA HHHHHHHHHHCCCCC | 33.57 | 115491747 | |
110 | S-palmitoylation | EERAGRHCGALRVLN HHHHHCCCCCEEECC | 3.08 | 21044946 | |
118 | Phosphorylation | GALRVLNSYWVGEDS CCEEECCCEECCCCC | 19.06 | 30257219 | |
119 | Phosphorylation | ALRVLNSYWVGEDST CEEECCCEECCCCCC | 11.75 | 28152594 | |
125 | Phosphorylation | SYWVGEDSTYKFFEV CEECCCCCCEEEEEE | 29.36 | 30622161 | |
126 | Phosphorylation | YWVGEDSTYKFFEVI EECCCCCCEEEEEEE | 42.95 | 30622161 | |
127 | Phosphorylation | WVGEDSTYKFFEVIL ECCCCCCEEEEEEEE | 15.11 | 23917254 | |
140 | Sumoylation | ILIDPFHKAIRRNPD EEECHHHHHHHHCCC | 45.98 | - | |
140 | Ubiquitination | ILIDPFHKAIRRNPD EEECHHHHHHHHCCC | 45.98 | 21906983 | |
140 | Ubiquitination | ILIDPFHKAIRRNPD EEECHHHHHHHHCCC | 45.98 | 21890473 | |
140 | Acetylation | ILIDPFHKAIRRNPD EEECHHHHHHHHCCC | 45.98 | 26051181 | |
153 | Acetylation | PDTQWITKPVHKHRE CCCCCCCCCCHHCHH | 35.59 | 23749302 | |
153 | Ubiquitination | PDTQWITKPVHKHRE CCCCCCCCCCHHCHH | 35.59 | 21890473 | |
153 | Ubiquitination | PDTQWITKPVHKHRE CCCCCCCCCCHHCHH | 35.59 | 21906983 | |
157 | Ubiquitination | WITKPVHKHREMRGL CCCCCCHHCHHHHCC | 44.59 | 21890473 | |
157 | Ubiquitination | WITKPVHKHREMRGL CCCCCCHHCHHHHCC | 44.59 | 21906983 | |
162 | Methylation | VHKHREMRGLTSAGR CHHCHHHHCCCCCCH | 32.01 | 115491727 | |
176 | Ubiquitination | RKSRGLGKGHKFHHT HHHCCCCCCCCCCHH | 63.99 | - | |
179 | Acetylation | RGLGKGHKFHHTIGG CCCCCCCCCCHHCCC | 55.87 | 25825284 | |
179 | Ubiquitination | RGLGKGHKFHHTIGG CCCCCCCCCCHHCCC | 55.87 | 21906983 | |
179 | 2-Hydroxyisobutyrylation | RGLGKGHKFHHTIGG CCCCCCCCCCHHCCC | 55.87 | - | |
183 | Phosphorylation | KGHKFHHTIGGSRRA CCCCCCHHCCCCHHH | 16.85 | 20068231 | |
187 | Phosphorylation | FHHTIGGSRRAAWRR CCHHCCCCHHHHHHH | 17.24 | 30108239 | |
197 | Phosphorylation | AAWRRRNTLQLHRYR HHHHHHCCCCCEECC | 17.67 | 30266825 | |
202 | Methylation | RNTLQLHRYR----- HCCCCCEECC----- | 37.20 | 115491737 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RL15_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RL15_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RL15_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
615550 | Diamond-Blackfan anemia 12 (DBA12) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-83, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-34; SER-97 AND SER-100,AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-97, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-34, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-34 AND THR-197, AND MASSSPECTROMETRY. |